Seeds Capital logo

Seeds Capital

Asia, Central Region, Singapore, Singapore

Description

Seeds Capital serves as the dedicated investment arm of Enterprise Singapore, the government agency championing enterprise development in the city-state. Its core mandate is to catalyze the growth of Singapore's startup ecosystem by co-investing alongside qualified third-party private investors. This unique co-investment model aims to mitigate risks for private capital providers while injecting crucial funding into promising early-stage companies. Seeds Capital primarily partners with venture capital funds, corporate venture arms, and family offices, leveraging their expertise and networks to support the development of innovative local enterprises.

The organization's investment strategy is firmly rooted in supporting Singapore-based startups across various high-growth sectors, particularly those with strong intellectual property or disruptive technologies. While not sector-specific in all its programs, there is a significant emphasis on deep tech areas such as advanced manufacturing, agri-food technology, medical technology, and urban solutions. Through schemes like Startup SG Equity, Seeds Capital actively participates in funding rounds from the seed stage through Series A, ensuring that promising ventures receive the necessary capital to scale their operations and commercialize their innovations.

Under the Startup SG Equity scheme, Seeds Capital typically co-invests up to 70% of the total qualified investment amount alongside private investors. For general technology startups, the government's co-investment is capped at S$5 million (approximately US$3.7 million) per company. For deep tech startups, recognizing the higher capital intensity and longer development cycles, this cap is extended to S$8 million (approximately US$5.92 million). While there isn't a fixed minimum, their participation in typical seed rounds means their co-investment can start from around US$100,000, depending on the overall round size and the private investor's contribution.

By acting as a strategic co-investor, Seeds Capital plays a pivotal role in bridging funding gaps and de-risking investments for private capital. This approach not only stimulates private sector participation in the venture landscape but also ensures that Singapore's most innovative startups have access to the resources needed to develop groundbreaking solutions and expand globally, reinforcing the nation's position as a vibrant hub for innovation and entrepreneurship.

Investor Profile

Seeds Capital has backed more than 51 startups, with 10 new investments in the last 12 months alone. The firm has led 3 rounds, about 6% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in Singapore, United States, Canada.
  • Strong thematic focus on Software, Biotechnology, Information Technology.
  • Led 1 rounds in the past year.
  • Typical check size: $103.6K – $5.9M.

Stage Focus

  • Series A (47%)
  • Seed (35%)
  • Series B (10%)
  • Series Unknown (6%)
  • Series C (2%)

Country Focus

  • Singapore (92%)
  • United States (4%)
  • Canada (2%)
  • New Zealand (2%)

Industry Focus

  • Software
  • Biotechnology
  • Information Technology
  • Health Care
  • Medical
  • Artificial Intelligence (Ai)
  • Food And Beverage
  • Agriculture
  • Biopharma
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Seeds Capital frequently co-invest with?

The Yield Lab Asia Pacific
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Wavemaker Partners
Asia, Central Region, Singapore, Singapore
Co-Investments: 10
Jungle Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
TNB Aura
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
ClavystBio
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Amasia
North America, California, United States, Burlingame
Co-Investments: 3
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 8
Airbus Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
Entrepreneur First
Europe, England, United Kingdom, London
Co-Investments: 5

Which angels does Seeds Capital often collaborate with?

AS
Asia, Singapore
Shared Deals: 1
Amit Pachisia
Asia, United Arab Emirates
Shared Deals: 1
Michael Gryseels
Asia, Singapore
Shared Deals: 3
Alex Turnbull
Asia, Singapore
Shared Deals: 1
Steve Melhuish
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
FX
Asia, Singapore
Shared Deals: 1
NE
North America, California, United States, San Francisco
Shared Deals: 1
DP
North America, Washington, United States, Seattle
Shared Deals: 1
CS
North America, Washington, United States, Kirkland
Shared Deals: 1
Nalin Advani
Asia, Tokyo, Japan, Tokyo
Shared Deals: 1

What are some of recent deals done by Seeds Capital?

Respiree

Singapore, Central Region, Singapore

Respiree is a healthcare service.

Health CareHome Health Care
Series AJul 23, 2025
Amount Raised: $11,600,000
VFlow Tech

Singapore, Central Region, Singapore

VFlow uses its unique IP to build safe, long-lasting, high performing low-cost flow batteries for large scale energy storage application.

BatteryElectronicsEnergyEnergy StorageRenewable EnergySoftware
Series BMay 14, 2025
Amount Raised: $20,500,000
Nuevocor

Singapore, Central Region, Singapore

Nuevocor operates as a preclinical-stage biotech company.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BMay 6, 2025
Amount Raised: $45,000,000
Histoindex

Singapore, Central Region, Singapore

HistoIndex is a MedTech spin-off company.

Biotechnology
Series UnknownMay 2, 2025
Amount Raised: $14,988
Groundup.ai

Singapore, Central Region, Singapore

Groundup.ai helps industrial companies prevent unplanned downtime using our ‘proprietary IOT sensors and AI platform’.

Artificial Intelligence (AI)Information TechnologyInternet of ThingsMachine LearningPredictive AnalyticsSoftware
Series AApr 21, 2025
Amount Raised: $4,250,000
Callio Therapeutics

Seattle, Washington, United States

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

BiotechnologyHealth CareMedical
Series AMar 3, 2025
Amount Raised: $187,000,000
GlobalTix

Singapore, Central Region, Singapore

GlobalTix is an online electronic ticketing platform for merchants and travel agents.

E-CommerceInformation TechnologyMobile AppsSoftwareTravel
Series BOct 11, 2024
Amount Raised: $4,980,461
Meridian Innovation

Singapore, Central Region, Singapore

Meridian Innovation is a developer of CMOS thermal imaging solutions for consumer and commercial applications.

ManufacturingSemiconductorSensor
Series UnknownOct 8, 2024
Amount Raised: $12,500,000
DiMuto

Singapore, Central Region, Singapore

DiMuto is an AgriFintech company that provides global AgriFood Trade Solutions powered by AI, data visibility and finance.

AgricultureAgTechBlockchainFinancial ServicesFinTechInformation TechnologySoftware
Series AAug 20, 2024
Amount Raised: $5,900,000
Aevice Health

Singapore, Central Region, Singapore

Aevice Health offers wearable devices for remote monitoring of respiratory conditions.

Health CareMedical DeviceWearables
SeedAug 9, 2024
Amount Raised: $7,000,000